Nova Patents
ATE548351T1

Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 29 January 2017, 9.7 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

16 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
DocumentOfficeKindDate
1073796United States of AmericaP
2119196United States of AmericaP
9701252United States of AmericaW

Members16

Family members, oldest first
DocumentOfficeKind
CA2244774A1CanadaA1
WO9727177A2World Intellectual Property Organization (WIPO)A2
AU2246697AAustraliaA
WO9727177A3World Intellectual Property Organization (WIPO)A3
EP0885192A1European Patent Office (EPO)A1
AU709190B2AustraliaB2
HK1017676A1Hong Kong, ChinaA1
US6066642AUnited States of AmericaA
JP2000516910AJapanA
CA2244774CCanadaC
JP4431638B2JapanB2
EP2311806A2European Patent Office (EPO)A2
EP2311806A3European Patent Office (EPO)A3
EP0885192B1European Patent Office (EPO)B1
ATE548351T1This recordAustriaT1
EP0885192B8European Patent Office (EPO)B8